CASI Pharmaceuticals, Inc. SEC filings

Filings

Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.

1. ROUTINE6-KCASI Pharmaceuticals, Inc.CASIFSep 4

   Foreign issuer report

2. ROUTINE6-KCASI Pharmaceuticals, Inc.CASIAug 14

   Foreign issuer report

3. ROUTINE6-KCASI Pharmaceuticals, Inc.CASIFAug 13

   Foreign issuer report

4. ROUTINE6-KCASI Pharmaceuticals, Inc.CASIFJul 15

   Foreign issuer report

5. ROUTINE6-KCASI Pharmaceuticals, Inc.CASIJun 29

   Foreign issuer report

6. NOTABLE25-NSECASI Pharmaceuticals, Inc.CASIFJun 23

   Delisting notice

   Nasdaq Stock Market LLC, filed by

7. ROUTINE6-KCASI Pharmaceuticals, Inc.CASIFJun 2

   Foreign issuer report

8. NOTABLESCHEDULE 13D/ACASI Pharmaceuticals, Inc.CASIFMay 18

   Ownership stake disclosure by Wei-Wu He (amended)

   Wei-Wu He, filed by

9. NOTABLE20-FCASI Pharmaceuticals, Inc.CASIFMay 15

   Annual report

10. ROUTINEDCASI Pharmaceuticals, Inc.CASIFApr 28

    Private placement notice

11. ROUTINE3CASI Pharmaceuticals, Inc.CASIFApr 23

    Thomas Folinsbee, new insider at CASIF

    Thomas Folinsbee, reporting

12. ROUTINENT 20-FCASI Pharmaceuticals, Inc.CASIFApr 21

    NT 20-F filing

13. ROUTINE3CASI Pharmaceuticals, Inc.CASIFApr 20

    Xuebo Zeng, new insider at CASIF

    Xuebo Zeng, reporting

14. ROUTINE6-KCASI Pharmaceuticals, Inc.CASIFApr 20

    Foreign issuer report

15. ROUTINE6-KCASI Pharmaceuticals, Inc.CASIFApr 20

    Foreign issuer report

16. ROUTINE3CASI Pharmaceuticals, Inc.CASIFApr 16

    Wei R Gao, new insider at CASIF

    Wei R Gao, reporting

17. ROUTINE6-KCASI Pharmaceuticals, Inc.CASIFApr 15

    Foreign issuer report

18. ROUTINE3CASI Pharmaceuticals, Inc.CASIFApr 13

    Kun Qian, new insider at CASIF

    Kun Qian, reporting

19. ROUTINE3CASI Pharmaceuticals, Inc.CASIFApr 7

    Hai Huang, new insider at CASIF

    Hai Huang, reporting

20. ROUTINE3CASI Pharmaceuticals, Inc.CASIFApr 3

    2 insider filings

    Chunhua Wang, new insider at CASIF

    Show all 2

    • 3New insider at CASIFApr 3
    • 3New insider at CASIFApr 3

    Chunhua Wang, reporting

21. ROUTINE3CASI Pharmaceuticals, Inc.CASIFMar 27

    Barbara Helene Hannelore Krebs-Pohl, new insider at CASIF

    Barbara Helene Hannelore Krebs-Pohl, reporting

22. ROUTINE3CASI Pharmaceuticals, Inc.CASIFMar 25

    Alex Wu, new insider at CASIF

    Alex Wu, reporting

23. NOTABLESCHEDULE 13D/ACASI Pharmaceuticals, Inc.CASIFMar 23

    Ownership stake disclosure by Wei-Wu He (amended)

    Wei-Wu He, filed by

24. ROUTINE3CASI Pharmaceuticals, Inc.CASIFMar 18

    Wei-Wu He, new insider at CASIF

    Wei-Wu He, reporting

25. ROUTINE3CASI Pharmaceuticals, Inc.CASIFMar 18

    James Huang, new insider at CASIF

    James Huang, reporting

26. ROUTINE6-KCASI Pharmaceuticals, Inc.CASIFMar 3

    Foreign issuer report

27. ROUTINEDCASI Pharmaceuticals, Inc.CASIFeb 26

    Private placement notice

28. ROUTINE6-KCASI Pharmaceuticals, Inc.CASIFeb 25

    Foreign issuer report

29. ROUTINE6-KCASI Pharmaceuticals, Inc.CASIFeb 20

    Foreign issuer report

30. ROUTINE6-KCASI Pharmaceuticals, Inc.CASIFeb 19

    Foreign issuer report

31. ROUTINESCHEDULE 13G/ACASI Pharmaceuticals, Inc.CASIFeb 17

    Ownership stake disclosure by Venrock Healthcare Capital Partners III, L.P. (amended)

    Venrock Healthcare Capital Partners III, L.P., filed by

32. ROUTINESCHEDULE 13G/ACASI Pharmaceuticals, Inc.CASIFeb 13

    Ownership stake disclosure by Foresite Capital Fund VI LP (amended)

    Foresite Capital Fund VI LP, filed by

33. ROUTINE6-KCASI Pharmaceuticals, Inc.CASIFeb 10

    Foreign issuer report

34. NOTABLESCHEDULE 13D/ACASI Pharmaceuticals, Inc.CASIFeb 10

    Ownership stake disclosure by Wei-Wu He (amended)

    Wei-Wu He, filed by

35. NOTABLESCHEDULE 13D/ACASI Pharmaceuticals, Inc.CASIJan 29

    Ownership stake disclosure by Wei-Wu He (amended)

    Wei-Wu He, filed by

36. ROUTINEDCASI Pharmaceuticals, Inc.CASIJan 28

    2 Form D filings

    Private placement notice

    Show all 2

    • DPrivate placement noticeJan 28
    • DPrivate placement noticeJan 28
37. ROUTINE6-KCASI Pharmaceuticals, Inc.CASIJan 22

    Foreign issuer report

38. NOTABLESCHEDULE 13D/ACASI Pharmaceuticals, Inc.CASIJan 20

    Ownership stake disclosure by Chi Sing Ho (amended)

    Chi Sing Ho, filed by

39. NOTABLESCHEDULE 13D/ACASI Pharmaceuticals, Inc.CASIJan 20

    Ownership stake disclosure by SPARKLE BYTE LTD (amended)

    SPARKLE BYTE LTD, filed by

40. ROUTINE6-KCASI Pharmaceuticals, Inc.CASIJan 13

    Foreign issuer report

41. NOTABLESCHEDULE 13D/ACASI Pharmaceuticals, Inc.CASIJan 9

    Ownership stake disclosure by Wei-Wu He (amended)

    Wei-Wu He, filed by

42. ROUTINE6-KCASI Pharmaceuticals, Inc.CASIDec 23, 2025

    Foreign issuer report

43. NOTABLESCHEDULE 13D/ACASI Pharmaceuticals, Inc.CASIDec 18, 2025

    Ownership stake disclosure by Wei-Wu He (amended)

    Wei-Wu He, filed by

44. NOTABLESCHEDULE 13D/ACASI Pharmaceuticals, Inc.CASIDec 17, 2025

    Ownership stake disclosure by Panacea Innovation Ltd (amended)

    Panacea Innovation Ltd, filed by

45. ROUTINE6-KCASI Pharmaceuticals, Inc.CASIDec 11, 2025

    Foreign issuer report

46. ROUTINESCHEDULE 13GCASI Pharmaceuticals, Inc.CASINov 26, 2025

    Ownership stake disclosure by Zhenfeng M Chen

    Zhenfeng M Chen, filed by

47. ROUTINE6-KCASI Pharmaceuticals, Inc.CASINov 19, 2025

    CASI Pharmaceuticals, Inc. filed 6-K

    • Form Type: 6-K
    • Filing Date: 2025-11-19
48. ROUTINE6-KCASI Pharmaceuticals, Inc.CASINov 14, 2025

    Foreign issuer report

Older filings on EDGAR